News & Announcements

  • Purchase of Kirkstall and CLN with Truetide plc

    /**/ RNS Number : 1881D Imaging Biometrics Limited 14 October 2025   14 October 2025   Imaging Biometrics Limited (“IBAI” or the “Company“)   Purchase of Kirkstall Limited and CLN with Truetide plc   Imaging Biometrics Limited (LSE: IBAI), is pleased to announce the purchase of 86.11% of the issued share capital of Kirkstall Limited

    Read more . . .

  • Vivan Therapeutics and IB Announce Partnership

    /**/ RNS Number : 0412C Imaging Biometrics Limited 03 October 2025     Imaging Biometrics Limited (“IB” or the “Company”)   Vivan Therapeutics and Imaging Biometrics Announce Strategic Partnership to Advance Gallium Maltolate for New Cancer Indications   The collaboration leverages innovative in vivo whole animal high-throughput drug screening platform to explore new anti-cancer uses

    Read more . . .

  • IB Enters Agreement with MedImageMetric

    /**/ RNS Number : 5731Z Imaging Biometrics Limited 16 September 2025   Imaging Biometrics Limited (the “Company”)   Imaging Biometrics Enters Agreement with MedImageMetric to Commercialize QSM Technology   September 16, 2025 – Imaging Biometrics, LLC (IB), a leading provider of advanced MRI analytics, is pleased to announce an agreement with MedImageMetric, LLC (MIM) to

    Read more . . .

  • Half-year Report

    /**/ RNS Number : 1953V Imaging Biometrics Limited 13 August 2025   13 August 2025 Imaging Biometrics, Limited (the “Company” or the “Group”) Half Yearly Report for the Period Ended 30 June 2025   The Board of Imaging Biometrics, Ltd is pleased to announce the Company’s half yearly report for the period ended 30 June

    Read more . . .

  • Grant of Share Options

    /**/ RNS Number : 4317U Imaging Biometrics Limited 07 August 2025     Imaging Biometrics Limited (“IB” or the “Company”)   Grant of Share Options   The Board of Directors of IB approved, at the February board meeting of the Company, the issuance of incentive share option awards (“Options”) to key personnel as part of

    Read more . . .

TOP